Logo Image

Podcasts

Recent Episodes

Bladder-sparing options for BCG-unresponsive non-muscle invasive bladder cancer have transformed since 2020, according to Saum Ghodoussipour, MD.
Rethinking BCG Failure and The Bladder-Sparing Boom in NMIBC
The FDA’s decision on iberdomide is a “landmark approval” for those with multiple myeloma, according to Surbhi Sidana, MD.
Unpacking Iberdomide’s FDA Approval and The Future of CELMoDs
Experts highlight the origins and significance of World Radiotherapy Awareness Day and discuss global access challenges surrounding modern radiation oncology.
Speaking With “One Voice” for World Radiotherapy Awareness Day
How Mentorship and Peer Support Help Oncologists Avoid Burnout
How Mentorship and Peer Support Help Oncologists Avoid Burnout
Experts discussed the rapidly expanding radiopharmaceutical paradigm and how to integrate such technology into real-world oncology practice.
Exploring the Future of Radiopharmaceutical Therapy in Oncology
Frank McCormick, PhD, FRS, DSc (Hon), spoke about how targeting KRAS may eventually lead to the prevention of pancreatic cancer.
How Will Successfully Targeting KRAS Change Pancreatic Cancer Treatment?
Experts highlight how AI-based tools can assist with digital pathology, documentation, medical imaging, and other relevant areas in genitourinary oncology.
What Role Will Artificial Intelligence Play in Genitourinary Oncology?
How to Treat Depression in Patients With Cancer: A Practical Framework
How to Treat Depression in Patients With Cancer: A Practical Framework
Two pharmacy specialists discuss real-world data and clinical trial findings on the use of CAR T-cell therapy for pediatric patients with hematologic cancers.
Exploring CAR-T Updates in Pediatric Acute Lymphoblastic Leukemia
Two hematologic oncology experts discuss operational and referral workflows, as well as barriers to access for CAR T-cell therapy in multiple myeloma.
What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care?

All series

Recent Episodes

Recent Episodes

Oncology On the Go With ASTCT Talks

Oncology On the Go With ASTCT Talks

ONCOLOGY Decoded

ONCOLOGY Decoded

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

FDA Approval Alert: The Need-to-Know

FDA Approval Alert: The Need-to-Know

Joshua Richter, MD, and Marco Davila, MD, PhD, discussed practical strategies for administering CAR T-cell therapy to patients with multiple myeloma. Their conversation touched upon key themes including navigating operational and referral workflows, dismantling access barriers to novel cellular therapies, and determining the proper candidates for treatment.

Exploring Practical CAR T Cell Use in Multiple Myeloma Care

Oncology-on-the-Go with Daniel C. McFarland, DO

Oncology-on-the-Go with Daniel C. McFarland, DO

All Podcasts